daratumumab
UkraineMedications containing this active substance
-
Darzalex®
Form: concentrate for infusion solution
Active substance Dosage daratumumab 20 mg/ml ATC: L01XC24
Manufacturer: Sygnus AG (manufacturing of unpackaged product, primary packaging, quality control; secondary packaging; batch release)